Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Field Cancerization Therapies for Management of Actinic Keratosis: A Narrative Review
Nathan Jetter, Neha Chandan, Stephanie Wang, et al.
American Journal of Clinical Dermatology (2018) Vol. 19, Iss. 4, pp. 543-557
Closed Access | Times Cited: 55

Showing 1-25 of 55 citing articles:

European consensus‐based interdisciplinary guideline for diagnosis, treatment and prevention of actinic keratoses, epithelial UV‐induced dysplasia and field cancerization on behalf of European Association of Dermato‐Oncology, European Dermatology Forum, European Academy of Dermatology and Venereology and Union of Medical Specialists (Union Européenne des Médecins Spécialistes)
Lidija Kandolf, Ketty Peris, Josep Malvehy, et al.
Journal of the European Academy of Dermatology and Venereology (2024) Vol. 38, Iss. 6, pp. 1024-1047
Closed Access | Times Cited: 21
Global Trends and Research Progress of Photodynamic Therapy in Skin Cancer: A Bibliometric Analysis and Literature Review
Jiachen Sun, Hongqing Zhao, Lin Fu, et al.
Clinical Cosmetic and Investigational Dermatology (2023) Vol. Volume 16, pp. 479-498
Open Access | Times Cited: 27
Field Cancerization Therapies for the Management of Actinic Keratosis: An Updated Review
Ishita Aggarwal, Carolina Puyana, Neha Chandan, et al.
American Journal of Clinical Dermatology (2024) Vol. 25, Iss. 3, pp. 391-405
Closed Access | Times Cited: 11
An Intelligent Mechanism to Detect Multi-Factor Skin Cancer
Abdullah Abdullah, Ansar Siddique, Kamran Shaukat, et al.
Diagnostics (2024) Vol. 14, Iss. 13, pp. 1359-1359
Open Access | Times Cited: 11
Efficacy and tolerability of tirbanibulin 1% ointment in the treatment of cancerization field: a real‐life Italian multicenter observational study of 250 patients
Gianluca Nazzaro, Andrea Carugno, Paolo Bortoluzzi, et al.
International Journal of Dermatology (2024) Vol. 63, Iss. 11, pp. 1566-1574
Open Access | Times Cited: 9
Field cancerization: Treatment
Christine Cornejo, Anokhi Jambusaria‐Pahlajani, Tyler J. Willenbrink, et al.
Journal of the American Academy of Dermatology (2020) Vol. 83, Iss. 3, pp. 719-730
Closed Access | Times Cited: 56
The conventional protocol vs. a protocol including illumination with a fabric‐based biophotonic device (the Phosistos protocol) in photodynamic therapy for actinic keratosis: a randomized, controlled, noninferiority clinical study
Serge Mordon, Anne‐Sophie Vignion‐Dewalle, Henry Abi Rached, et al.
British Journal of Dermatology (2019)
Open Access | Times Cited: 41
A trial‐based cost‐effectiveness analysis of topical 5‐fluorouracil vs. imiquimod vs. ingenol mebutate vs. methyl aminolaevulinate conventional photodynamic therapy for the treatment of actinic keratosis in the head and neck area performed in the Netherlands
Maud H.E. Jansen, J.P.H.M. Kessels, I. Merks, et al.
British Journal of Dermatology (2020) Vol. 183, Iss. 4, pp. 738-744
Open Access | Times Cited: 34
Pan-viral protection against arboviruses by activating skin macrophages at the inoculation site
Steven R. Bryden, Marieke Pingen, Daniella Lefteri, et al.
Science Translational Medicine (2020) Vol. 12, Iss. 527
Open Access | Times Cited: 34
Pharmacokinetics, Safety, and Tolerability of a Single 5‐Day Treatment of Tirbanibulin Ointment 1% in 100 cm2: A Phase 1 Maximal‐Use Trial in Patients with Actinic Keratosis
Janet DuBois, Terry M. Jones, Mark S. Lee, et al.
Clinical Pharmacology in Drug Development (2024) Vol. 13, Iss. 2, pp. 208-218
Open Access | Times Cited: 4
Daylight Photodynamic Therapy for Actinic Keratosis and Field Cancerization: A Narrative Review
Elena Sotiriou, Dimitra Kiritsi, Nikolaos Chaitidis, et al.
Cancers (2025) Vol. 17, Iss. 6, pp. 1050-1050
Open Access
Clinical features and outcome of dermal squamous cell carcinoma in 193 dogs (1987‐2017)
Jennifer L. Willcox, Stanley L. Marks, Yu Ueda, et al.
Veterinary and Comparative Oncology (2019) Vol. 17, Iss. 2, pp. 130-138
Closed Access | Times Cited: 27
Photodynamic Therapy with 5-aminolevulinic Acid 10% Gel and Red Light for the Treatment of Actinic Keratosis, Nonmelanoma Skin Cancers, and Acne: Current Evidence and Best Practices.
Nathalie C. Zeitouni, Neal Bhatia, Roger I. Ceilley, et al.
PubMed (2021) Vol. 14, Iss. 10, pp. E53-E65
Closed Access | Times Cited: 22
Skin cancer prevention – Recent advances and unmet challenges
Mahsa Mortaja, Shadmehr Demehri
Cancer Letters (2023) Vol. 575, pp. 216406-216406
Open Access | Times Cited: 8
Cutaneous squamous cell carcinoma. Italian Guidelines by SIDeMaST adapted to and updating EADO/EDF/EORTC guidelines
Ketty Peris, Mauro Alaibac, Giuseppe Argenziano, et al.
Giornale Italiano di Dermatologia e Venereologia (2018) Vol. 153, Iss. 6
Closed Access | Times Cited: 26
AK-DL: A Shallow Neural Network Model for Diagnosing Actinic Keratosis with Better Performance than Deep Neural Networks
Liyang Wang, Angxuan Chen, Yan Zhang, et al.
Diagnostics (2020) Vol. 10, Iss. 4, pp. 217-217
Open Access | Times Cited: 23
Management Pearls on the Treatment of Actinic Keratoses and Field Cancerization
Jaime Piquero‐Casals, D. Morgado‐Carrasco, Yolanda Gilaberte, et al.
Dermatology and Therapy (2020) Vol. 10, Iss. 5, pp. 903-915
Open Access | Times Cited: 23
Randomized controlled trial of fractionated laser resurfacing on aged skin as prophylaxis against actinic neoplasia
Dan F. Spandau, Roy Chen, Jeffrey J. Wargo, et al.
Journal of Clinical Investigation (2021) Vol. 131, Iss. 19
Open Access | Times Cited: 19
Updates on Treatment Approaches for Cutaneous Field Cancerization
Alisen Huang, Julie Nguyen, Evan Austin, et al.
Current Dermatology Reports (2019) Vol. 8, Iss. 3, pp. 122-132
Open Access | Times Cited: 22
Topical Immunotherapy for Actinic Keratosis and Field Cancerization
Laura Bernal Masferrer, Tamara Gracia‐Cazaña, Isabel Bernad, et al.
Cancers (2024) Vol. 16, Iss. 6, pp. 1133-1133
Open Access | Times Cited: 2
Efficacy and safety of photodynamic therapy with amino-5-laevulinate nanoemulsion versus methyl-5-aminolaevulinate for actinic keratosis: A meta-analysis
Chen Fu, Bo‐Hua Kuang, Qin Li, et al.
Photodiagnosis and Photodynamic Therapy (2019) Vol. 27, pp. 408-414
Closed Access | Times Cited: 16
Topical Photodynamic Therapy with Different Forms of 5-Aminolevulinic Acid in the Treatment of Actinic Keratosis
Joanna Bartosińska, Paulina Szczepanik-Kułak, Dorota Raczkiewicz, et al.
Pharmaceutics (2022) Vol. 14, Iss. 2, pp. 346-346
Open Access | Times Cited: 9
An Actinic Keratosis Auxiliary Diagnosis Method Based on an Enhanced MobileNet Model
Shiyang Li, Chengquan Li, Qicai Liu, et al.
Bioengineering (2023) Vol. 10, Iss. 6, pp. 732-732
Open Access | Times Cited: 5
Clinical utility of ingenol mebutate in the management of actinic keratosis: perspectives from clinical practice
Nevena Skroza, Nicoletta Bernardini, Ilaria Proietti, et al.
Therapeutics and Clinical Risk Management (2018) Vol. Volume 14, pp. 1879-1885
Open Access | Times Cited: 16
Risk Factors for Keratinocyte Carcinoma in Recipients of Allogeneic Hematopoietic Cell Transplants
Jeffrey F. Scott, Kevin Brough, Konstantin V. Grigoryan, et al.
JAMA Dermatology (2020) Vol. 156, Iss. 6, pp. 631-631
Open Access | Times Cited: 14
Page 1 - Next Page

Scroll to top